Morisaki Masuo
Tokyo Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Morisaki Masuo.
Journal of Steroid Biochemistry | 1980
Morisaki Masuo; Duque Carmenza; Ikekawa Nobuo; Shikita Mikio
Abstract Thirty four cholesterol analogues with modified side chain were chemically synthesized and incubated with a highly purified preparation of cytochrome P-450scc. It was shown that five to ten carbon sidechain are required for the cleavage reaction to occur and that structural modification in the side-chain especially around C-23 and C-25 positions either decreases or increases the yield of pregnenolone. The results suggest that the enzyme requires a relatively low, but not totally unlimited specificity for the side-chain structure of the substrate.
Steroids | 1974
Morisaki Masuo; Ohotaka Hiroshi; Awata Norio; Ikekawa Nobuo; Horie Yasuhiro; Nakasone Shoichi
Abstract Several possible substrates and intermediates of phytosterol dealkylation were tested for their ability to support growth and development in the silkworm, Bombyx mori . These compounds were classified into “effective” (fully substitutive for cholesterol), “partially effective” (partially supporting growth) and “ineffective” These results are discussed in relation to the mechanism of phytosterol dealkylation in insects.
Steroids | 1974
Fujimoto Yoshinori; Morisaki Masuo; Ikekawa Nobuo; Horie Yasuhiro; Nakasone Shoichi
Abstract 24,28-Iminofucosterol (I) has been synthesized from fucosterol acetate via addition of iodine isocyanate. The steroidal aziridine (I) disrupted normal growth and development of larvae of the silkworm, Bombyx mori and was found to be a potent inhibitor of dealkylation of β-sitosterol.
Journal of Steroid Biochemistry | 1982
Morisaki Masuo; Duque Carmenza; Takane Kumiko; Ikekawa Nobuo; Shikita Mikio
Abstract Eight cholesterol analogs with modified A/B ring were incubated with a highly purified preparation of cytochrome P-450 scc . It was shown that only the side chain of 3-epicholesterol and cholestenone were cleaved, whereas none of cholesterol esters were the substrate for P-450 scc .
Journal of Steroid Biochemistry | 1979
Koizumi Naoyuki; Morisaki Masuo; Ikekawa Nobuo; Tanaka Yoko; Hector F. DeLuca
Abstract Because 1,25-dihydroxy vitamin D undergoes side-chain cleavage and oxidation in vivo , an anticipated metabolite is 1α-hydroxy-trisnor-vitamin D 3 24-oic acid. A synthesis for this metabolite and trisnor-vitamin D 3 24-oic acid has been devised. Baeyer-Villiger rearrangement of 5,6-dibromo-24-oxo-cholesteryl acetate and its 1α-acetoxyl analog gave the corresponding cholenoate derivatives, and those were converted to trisnor-vitamin D 3 24-oic acid and its 1α-hydroxyl analog, respectively. The 1α-hydroxy-25,26,27-trisnor-vitamin D 3 24-oic acid (1α-OH-24-COOH trisnor-vitamin D 3 ) was tested for biological activity using rats fed a low calcium, vitamin D-deficient diet. It stimulated intestinal calcium transport 6 h after intravenous administration although the response is significantly less than that to an identical base of 1,25-dihydroxy vitamin D 3 (1,25-(OH) 2 D 3 ). This compound given at 125 ng per rat did not stimulate bone calcium mobilization.
Archive | 1976
Takeshita Toru; Hashimoto Yoshinobu; Kawashima Hiroyuki; Ishimoto Sachio; Ikekawa Nobuo; Morisaki Masuo
Archive | 1973
Ikekawa Nobuo; Morisaki Masuo
Archive | 1986
De Luca Hector F; Tanaka Yoko; Ikekawa Nobuo; Morisaki Masuo; Oshida Jun-Ichi
Archive | 1985
Deluca Hector F; Ikekawa Nobuo; Tanaka Yoko; Morisaki Masuo; Oshida Jun-Ichi
Archive | 1985
Deluca Hector F; Ikekawa Nobuo; Tanaka Yoko; Morisaki Masuo; Oshida Jun-Ichi